HLA class-I-peptide stability mediates CD8+ T cell immunodominance hierarchies and facilitates HLA-associated immune control of HIV

HLA I类肽的稳定性介导CD8+ T细胞的免疫优势等级,并促进HLA相关的HIV免疫控制。

阅读:3
作者:Clarety Kaseke ,Ryan J Park ,Nishant K Singh ,Dylan Koundakjian ,Arman Bashirova ,Wilfredo F Garcia Beltran ,Overbeck C Takou Mbah ,Jiaqi Ma ,Fernando Senjobe ,Jonathan M Urbach ,Anusha Nathan ,Elizabeth J Rossin ,Rhoda Tano-Menka ,Ashok Khatri ,Alicja Piechocka-Trocha ,Michael T Waring ,Michael E Birnbaum ,Brian M Baker ,Mary Carrington ,Bruce D Walker ,Gaurav D Gaiha

Abstract

Defining factors that govern CD8+ T cell immunodominance is critical for the rational design of vaccines for viral pathogens. Here, we assess the contribution of human leukocyte antigen (HLA) class-I-peptide stability for 186 optimal HIV epitopes across 18 HLA alleles using transporter associated with antigen processing (TAP)-deficient mono-allelic HLA-expressing cell lines. We find that immunodominant HIV epitopes increase surface stabilization of HLA class-I molecules in comparison to subdominant epitopes. HLA class-I-peptide stability is also strongly correlated with overall immunodominance hierarchies, particularly for epitopes from high-abundance proteins (e.g., Gag). Moreover, HLA alleles associated with HIV protection are preferentially stabilized by epitopes derived from topologically important viral regions at a greater frequency than neutral and risk alleles. These findings indicate that relative stabilization of HLA class-I is a key factor for CD8+ T cell epitope immunodominance hierarchies, with implications for HIV control and the design of T-cell-based vaccines.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。